β¨ Medicines Classification and Approval
NEW ZEALAND GAZETTE
No. 39
Manufacturer(s):
Schering-Plough Company, Brinny, Innishannon, County Cork, Ireland
Schering-Plough Products Inc, Las Piedras, Puerto Rico
New Zealand Sponsor:
Schering-Plough Pty Limited
Product:
Sinus & Nasal Decongestant
Active Ingredient(s):
Pseudoephedrine hydrochloride 60mg
Dosage Form:
Tablet
New Zealand Sponsor:
PSM Healthcare Limited
Manufacturer(s):
PSM Healthcare Limited, Wiri, Auckland
Dated this 7th day of April 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go2630
Classification of Medicines
Pursuant to section 106 (1) of the Medicines Act 1981, I, G. R. Boyd, Chief Advisor, Safety and Regulation, acting under delegated authority, hereby declare the following:
-
The medicines listed in Schedule 1 to this notice are classified as prescription medicines.
-
The medicines listed in Schedule 2 to this notice are classified as restricted medicines.
-
The medicines listed in Schedule 3 to this notice are classified as pharmacy-only medicines.
Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.
Unless specific reference is made otherwise, every reference applies also to medicines that are:
(a) Preparations and admixtures containing any proportion of any substance listed in the notice;
(b) Salts and esters of any substance listed in the notice;
(c) Preparations or extracts of biological materials listed in the notice;
(d) Salts or oxides of elements listed in the notice.
Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol or element unless specifically stated otherwise.
Schedule 1
Prescription Medicines
acetanilides
acetylmethyldimethoxyimidophenylhydrazine
acokanthera
adonis
adrenaline; in medicines containing more than 1%
aldesleukin
ambenonium
amfebutamone
ammi visnaga
amyl nitrite; except when sold from outlets licensed under the Toxic Substances Regulations 1983 to sell sodium cyanide paste for the purpose of vertebrate pest control
ancestim
antithrombin III
apocynum
apovirdine
azelastine; for ophthalmic use
bambuterol
becaplermin
benzoyl metronidazole
bivalirudin
bufexamac; except in suppositories or medicines for dermal use containing 5% or less
bupropion
butyl nitrite
calotropis
camphorated oil
camphotamide
capecitabine
celecoxib
cetirizine; except for oral use
cetrorelix
cholera vaccine
cidofovir
clenbuterol
clioquinol
clorprenaline
convallaria
coronilla
cymarin
cysteamine
dalfopristin
debrisoquine
delavirdine
demecarium
diethazine
dihydralazine
di-iodohydroxyquinoline; except for vaginal use
dipivefrin
diphemanil; except for dermal use
dofetilide
efavirenz
eleriptan
entacapone
eptifibatide
erysimum
ethopropazine
etilefrine
felypressin
fencamfamin
fenpropex
fexofenadine; except for oral use
fluticasone; except when specified elsewhere in the Schedule
fosfestrol
fosphenytoin
galanthus
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2000, No 39
Gazette.govt.nz —
NZ Gazette 2000, No 39
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare7 April 2000
Medicines Act 1981, New Medicines, Sinus & Nasal Decongestant, Pseudoephedrine hydrochloride
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Classification of Medicines
π₯ Health & Social WelfareMedicines Act 1981, Prescription Medicines, Restricted Medicines, Pharmacy-Only Medicines, Classification
- G. R. Boyd, Chief Advisor, Safety and Regulation